ebvcs5 (fluidigm)
fluidigm is a verified supplier 
fluidigm manufactures this product 
94
Structured Review
fluidigm
ebvcs5
Ebvcs5, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ebvcs5/Anti-Human+CD23+(EBVCS-5)-160Gd/pmc12970582-655-7-9
Average 94 stars, based on 1 article reviews
Ebvcs5, supplied by fluidigm, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ebvcs5/Anti-Human+CD23+(EBVCS-5)-160Gd/pmc12970582-655-7-9
Average 94 stars, based on 1 article reviews
ebvcs5 - by Bioz Stars,
2026-11
94/100 stars
Images
Related Articles
Control:Article Title: NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors Article Snippet: , 160 , Gd , CD23 , Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Article Snippet: Experiment Gene Primer Source Catalog # or primer sequence (5' --> 3') qPCR CCL3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3, Human qHsaCED0038633 qPCR CCL3L1 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L1, Human qHsaCED0037376 qPCR CCL3L3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L3, Human qHsaCED0041794 qPCR CCL4 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL4, Human qHsaCED0020005 qPCR ACTB F1 Synthesized at Stanford PAN facility CAGCACAATGAAGATCAAGAT CA qPCR ACTB R1 Synthesized at Stanford PAN facility CGGACTCGTCATACTCCTGC qPCR ACTB F2 Synthesized at Stanford PAN facility GCTATCCAGGCTGTGCTATCC qPCR ACTB R2 Synthesized at Stanford PAN facility CTTCTCCAGGGAGGAGCTGG qPCR GAPDH F1 Synthesized at Stanford PAN facility ATGCCATCACTGCCACCCAG qPCR GAPDH R1 Synthesized at Stanford PAN facility CCTGCTTCACCACCTTCTTG qPCR GAPDH F2 Synthesized at Stanford PAN facility TCACTGGCATGGCCTTCCGTG qPCR GAPDH R2 Synthesized at Stanford PAN facility GCCATGAGGTCCACCACCCTG PCR CD300A F Synthesized at Stanford PAN facility GGAGGGTCCTGGAGAGACTC PCR CD300A R Synthesized at Stanford PAN facility TACCTGAGCCCCCTTCCAAA Table S7: Primers used in PCR and qPCR analyses – related to Figures 3 and S4. Injection:Article Title: NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors Article Snippet: , 160 , Gd , CD23 , Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Article Snippet: Experiment Gene Primer Source Catalog # or primer sequence (5' --> 3') qPCR CCL3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3, Human qHsaCED0038633 qPCR CCL3L1 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L1, Human qHsaCED0037376 qPCR CCL3L3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L3, Human qHsaCED0041794 qPCR CCL4 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL4, Human qHsaCED0020005 qPCR ACTB F1 Synthesized at Stanford PAN facility CAGCACAATGAAGATCAAGAT CA qPCR ACTB R1 Synthesized at Stanford PAN facility CGGACTCGTCATACTCCTGC qPCR ACTB F2 Synthesized at Stanford PAN facility GCTATCCAGGCTGTGCTATCC qPCR ACTB R2 Synthesized at Stanford PAN facility CTTCTCCAGGGAGGAGCTGG qPCR GAPDH F1 Synthesized at Stanford PAN facility ATGCCATCACTGCCACCCAG qPCR GAPDH R1 Synthesized at Stanford PAN facility CCTGCTTCACCACCTTCTTG qPCR GAPDH F2 Synthesized at Stanford PAN facility TCACTGGCATGGCCTTCCGTG qPCR GAPDH R2 Synthesized at Stanford PAN facility GCCATGAGGTCCACCACCCTG PCR CD300A F Synthesized at Stanford PAN facility GGAGGGTCCTGGAGAGACTC PCR CD300A R Synthesized at Stanford PAN facility TACCTGAGCCCCCTTCCAAA Table S7: Primers used in PCR and qPCR analyses – related to Figures 3 and S4. Activity Assay:Article Title: NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors Article Snippet: , 160 , Gd , CD23 , Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Article Snippet: Experiment Gene Primer Source Catalog # or primer sequence (5' --> 3') qPCR CCL3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3, Human qHsaCED0038633 qPCR CCL3L1 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L1, Human qHsaCED0037376 qPCR CCL3L3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L3, Human qHsaCED0041794 qPCR CCL4 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL4, Human qHsaCED0020005 qPCR ACTB F1 Synthesized at Stanford PAN facility CAGCACAATGAAGATCAAGAT CA qPCR ACTB R1 Synthesized at Stanford PAN facility CGGACTCGTCATACTCCTGC qPCR ACTB F2 Synthesized at Stanford PAN facility GCTATCCAGGCTGTGCTATCC qPCR ACTB R2 Synthesized at Stanford PAN facility CTTCTCCAGGGAGGAGCTGG qPCR GAPDH F1 Synthesized at Stanford PAN facility ATGCCATCACTGCCACCCAG qPCR GAPDH R1 Synthesized at Stanford PAN facility CCTGCTTCACCACCTTCTTG qPCR GAPDH F2 Synthesized at Stanford PAN facility TCACTGGCATGGCCTTCCGTG qPCR GAPDH R2 Synthesized at Stanford PAN facility GCCATGAGGTCCACCACCCTG PCR CD300A F Synthesized at Stanford PAN facility GGAGGGTCCTGGAGAGACTC PCR CD300A R Synthesized at Stanford PAN facility TACCTGAGCCCCCTTCCAAA Table S7: Primers used in PCR and qPCR analyses – related to Figures 3 and S4. Immunohistochemistry:Article Title: NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors Article Snippet: , 160 , Gd , CD23 , Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Article Snippet: Experiment Gene Primer Source Catalog # or primer sequence (5' --> 3') qPCR CCL3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3, Human qHsaCED0038633 qPCR CCL3L1 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L1, Human qHsaCED0037376 qPCR CCL3L3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L3, Human qHsaCED0041794 qPCR CCL4 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL4, Human qHsaCED0020005 qPCR ACTB F1 Synthesized at Stanford PAN facility CAGCACAATGAAGATCAAGAT CA qPCR ACTB R1 Synthesized at Stanford PAN facility CGGACTCGTCATACTCCTGC qPCR ACTB F2 Synthesized at Stanford PAN facility GCTATCCAGGCTGTGCTATCC qPCR ACTB R2 Synthesized at Stanford PAN facility CTTCTCCAGGGAGGAGCTGG qPCR GAPDH F1 Synthesized at Stanford PAN facility ATGCCATCACTGCCACCCAG qPCR GAPDH R1 Synthesized at Stanford PAN facility CCTGCTTCACCACCTTCTTG qPCR GAPDH F2 Synthesized at Stanford PAN facility TCACTGGCATGGCCTTCCGTG qPCR GAPDH R2 Synthesized at Stanford PAN facility GCCATGAGGTCCACCACCCTG PCR CD300A F Synthesized at Stanford PAN facility GGAGGGTCCTGGAGAGACTC PCR CD300A R Synthesized at Stanford PAN facility TACCTGAGCCCCCTTCCAAA Table S7: Primers used in PCR and qPCR analyses – related to Figures 3 and S4. Generated:Article Title: NKG2A+ NK Cell Cytotoxicity of Epstein-Barr Virus Infected B Cells is Mediated Through the NKG2D and NKp30 Activating Receptors Article Snippet: , 160 , Gd , CD23 , Article Title: Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders Article Snippet: Experiment Gene Primer Source Catalog # or primer sequence (5' --> 3') qPCR CCL3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3, Human qHsaCED0038633 qPCR CCL3L1 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L1, Human qHsaCED0037376 qPCR CCL3L3 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL3L3, Human qHsaCED0041794 qPCR CCL4 F and R 20x mix Bio-Rad, PrimePCRTM SYBR® Green Assay: CCL4, Human qHsaCED0020005 qPCR ACTB F1 Synthesized at Stanford PAN facility CAGCACAATGAAGATCAAGAT CA qPCR ACTB R1 Synthesized at Stanford PAN facility CGGACTCGTCATACTCCTGC qPCR ACTB F2 Synthesized at Stanford PAN facility GCTATCCAGGCTGTGCTATCC qPCR ACTB R2 Synthesized at Stanford PAN facility CTTCTCCAGGGAGGAGCTGG qPCR GAPDH F1 Synthesized at Stanford PAN facility ATGCCATCACTGCCACCCAG qPCR GAPDH R1 Synthesized at Stanford PAN facility CCTGCTTCACCACCTTCTTG qPCR GAPDH F2 Synthesized at Stanford PAN facility TCACTGGCATGGCCTTCCGTG qPCR GAPDH R2 Synthesized at Stanford PAN facility GCCATGAGGTCCACCACCCTG PCR CD300A F Synthesized at Stanford PAN facility GGAGGGTCCTGGAGAGACTC PCR CD300A R Synthesized at Stanford PAN facility TACCTGAGCCCCCTTCCAAA Table S7: Primers used in PCR and qPCR analyses – related to Figures 3 and S4. |
